Pemphigus vegetans is an unusual form of pemphigus vulgaris. Pemphigus of the head and neck region is usually found in areas with mucosa, such as the mouth and pharynx. We present a fascinating case of pemphigus vegetans arising from the nasal dorsum that completely deformed the external nose of a 43-year-old woman. The patient was treated successfully with high-dose prednisone.
Introduction
Pemphigus vegetans (PVeg) is a subtype of pemphigus vulgaris (PV); it accounts for approximately 1 to 5% of all cases of PV. 1 PVeg is characterized by fungoid vegetations, called hypertrophic papillated plaques, which form on the erosions after the bullae have been ruptured. However, the overall tendency for bullae formation is less in PVeg than it is in PV. 2 There are two distinguishable subtypes of PVeg: the Neumann type and the Hallopeau type. [3] [4] [5] In the Neumann type, the appearance of the oral lesions is similar to that of the lesions seen in typical PV, and they evolve into vegetating plaques. The Neumann type has an aggressive and unremitting course, and the prognosis is similar to that of classic PV. The Hallopeau type is characterized by pustular lesions on the erosions. It has a more benign course, and relapses are few.
In this article, we describe an atypical presentation of massive PVeg.
Case report
A 43-year-old woman presented to the ENT clinic at Maricopa Medical Center in Phoenix with a progressively enlarging nasal mass. She had first noticed a small crusting area on her nasal alae 19 months earlier. The lesion grew slowly, and the patient was eventually treated with oral antibiotics a few months later at another institution for a severe case of impetigo. After she failed to respond to oral treatment, she was switched to 3 weeks of intravenous vancomycin, but again, there was no response. At that point, she underwent biopsies and was diagnosed with squamous cell carcinoma (SCC). The results of immunofluorescence staining and tests for antinuclear antibodies and human immunodeficiency virus were negative. Her erythrocyte sedimentation rate and blood panels were normal.
After the patient was told that she would require a partial rhinectomy, she was referred to our clinic for a second opinion. On presentation, a large fungating mass was seen encompassing the entire lower nose and extending into the philtrum of the upper lip (figure, A). An eczematous process was seen along the right medial canthus, and it extended into the upper eyelid. The patient's clinical history was significant for asthma and untreated hypertension. Her medications were albuterol and temazepam. The only other pertinent history was an incident 10 months earlier when said she might have been bitten by insects while she was on vacation in the Caribbean.
Suspecting that the lesion did not represent an SCC, we took the patient to the operating room for additional biopsies, which did not demonstrate any malignancy. The biopsy samples were sent to the Armed Forces Institute of Pathology (AFIP) for further review. At the AFIP, the specimens were described as representing a mixed inflammatory cell infiltrate that included a large number of eosinophils and plasma cells. Pseudoepitheliomatous hyperplasia was prominent, and intraepidermoid microabscesses and eosinophilic spongiosis were present. The AFIP pathologists suspected that the patient might have the PVeg variant of pemphigus. No organisms were ever identified on pathology or culture.
The patient was started on high-dose prednisone at 60 mg/day for 2 weeks, and the lesion began to rapidly regress. The dosage was decreased over 1 month, and Volume 91, Number 1 www.entjournal.com  E15 PemPhigus vegetans of the nose papillomatosis and hyperkeratosis with no eosinophilic microabscesses. 6 Our pathology report from the AFIP indicated mixed inflammation with pseudoepitheliomatous hyperplasia, hypereosinophilia, and intraepidermal eosinophilic microabscesses; the latter two findings are more typical of the Hallopeau type of PVeg.
PVeg has been reported in paraneoplastic syndromes (5 to 12% of cases), [8] [9] [10] and it has been associated with the use of captopril, penicillamine, and intranasal heroin, 1 although the exact causative pathophysiology is unknown.
Once the diagnosis of PVeg was established in our case, high-dose oral prednisone (60 mg/day) resulted in a rapid and marked improvement in the patient's clinical status.
the patient experienced a near-complete regression (figure, B) . She was maintained on a prednisone regimen of 30 mg/ day. Thereafter, whenever the dosage would be lowered, the lesion would recur. She was referred to rheumatology for ongoing maintenance therapy with prednisone.
Discussion
The differential diagnoses that were considered in this case were unusual nasal skin diseases such as rhinoscleroma, blastomycosis, coccidiomycosis, leishmaniasis, and Mycobacterium leprae infection. The patient's history of nonresponse to antibiotics indicated either a fungal, parasitic, or mycobacterial etiology. Subsequent serologic tests for coccidiomycosis and tuberculosis were negative. Visually, the lesion did bear some resemblance to an SCC, but upon closer inspection, it appeared more symmetrical and well circumscribed than a typical SCC. Also, there were areas of eczema that extended into the lip and medial canthus that would not be found in SCC.
PVeg, also called pyodermites vegetantes, was first described as a variant of PV by Neumann in 1876. 3, 4 Hallopeau described a second variant as "verrucous, cobblestoned plaques" 13 years later in Paris. 5 The mean age at onset of PVeg is 40 to 50 years, which is somewhat younger than the mean age seen for PV, which is 55 years. 6 PVeg lesions predominantly involve the intertriginous areas (groin/axilla), scalp, face, and mucous membranes. Oral involvement has been reported in 60 to 80% of PV cases and almost invariably in PVeg cases. 6 A characteristic of PVeg is a cerebriform tongue with a pattern of sulci and gyri on the dorsum. 2 Nasal lesions are seen in 62 to 83% of PV cases, and pharyngeal involvement in 75 to 86%. 6, 7 With the high frequency of ENT involvement in PV, it is important to consider PVeg in patients with atypical PV lesions.
Histopathologic examination of early PVeg lesions will show suprabasal acantholysis. Additionally, the Hallopeau type exhibits eosinophilic intraepidermal microabscesses, and the Neumann type shows intraepidermal vesicles. 8 These characteristics differ from those of PV in that PVeg is associated with an increased eosinophilic response, formation of microabscesses, and a greater extent of vesiculation. 2 Late lesions exhibit
Figure. Photos demonstrate the massive intranasal lesion at presentation (A) and resolution after 1 month of prednisone treatment (B).
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